• Extends Mednow’s growing national infrastructure and presence, demonstrating Mednow’s deep commitment to meeting patients where they are to provide holistic, private, pharmacist-led patient care.
• Initial focus on specialty pharmacy treating complex conditions with new pharmacological interventions, including screening and treatment of hepatitis C with the goal to eliminate the disease in Canada by 2030.

Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW) (OTCQX:MDNWF) Canada’s on-demand pharmacy, is officially open to serve patients in Alberta.

The Mednow Alberta pharmacy is located at 38, 3250 Sunridge Way NE, Calgary AB and offers a full suite of pharmacy-centred care and services with particular initial focus on specialty pharmacy, further expanding the company’s presence in the specialty pharmacy category.

Specialty pharmacy implements new pharmacological interventions, taking an active role in helping patients manage complex conditions with the latest treatments, monitoring and advice.

With advancements in screening and new specialty pharmacy treatments available through Mednow’s partnership agreement with HepCURE, this expansion marks another milestone in the shared goal to eliminate Hepatitis C in Canada by 2030.

In Alberta, licensed pharmacists have a broad scope of practice including the ability to prescribe for certain conditions, extend, adapt and manage prescriptions, order and interpret lab tests, administer vaccines and make therapeutic substitutions as needed.

The Mednow Alberta pharmacy includes space for private pharmacist consultations, further demonstrating the company’s deep commitment to holistic, private, pharmacist-led patient care.

“We’re thrilled to deepen our presence in Alberta, in line with our goal of being a truly national pharmacy with presence all across Canada to serve Mednow patients where they live and work,” said Ali Reyhany, Mednow CEO. “Expanding Mednow’s footprint ensures we are able to deliver on our core commitment of providing the highest level of care and attention to individual patients and other healthcare practitioners, all while driving sustainable business growth for Mednow.”

About Mednow

Mednow (TSXV: MNOW) (OTCQX:MDNWF) is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home delivery of medications, doctor consultations, a user-friendly interface for easy upload, transfer, and refill of prescriptions, access to healthcare professionals through an intuitive chat experience and the specialized PillSmart™ system that packages prescriptions in easy to use daily dose packs, each labelled with the date and time of the next dose.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements:

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information, including statements relating to: Mednow’s plan to expand its operations and open fulfillment centres in certain locations in 2022, Mednow’s goal of integrating the technology of its strategic business acquisitions with its core fulfillment pharmacies, the optimization of Mednow’s PillSmart TM and nutraceutical offerings, Mednow’s ability to connect with employers, specialty doctors and large pharmacies, and Mednow’s ability to acquire customers and lower costs.

Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Risk factors are set out in the Company’s final long form prospectus dated February 26, 2021 available for review on the Company’s profile at www.sedar.co. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

This news release also contains future-oriented financial information and financial outlook information (collectively, “FOFI”) as defined under Canadian securities laws, prepared by Mednow’s management about Mednow’s reasonably estimated prospective results of operations, revenue, sales, and components thereof, all of which are subject to the same assumptions, risks factors, limitations and qualifications set forth in the above paragraphs. Readers are cautioned that FOFI are not guarantees of future performance, and should not be considered as such, since actual results may differ materially from those expressed in FOFI. Mednow and its management believe that FOFI has been prepared on a reasonable basis, reflecting management’s best estimates and judgements. FOFI contained in this news release were made as of the date of this news release and is provided for the purpose of describing the belief of Mednow’’s management of the anticipated effects of the financing on Mednow’s business operations.

As a result, there can be no assurance that forward-looking information or FOFI will prove to be accurate, as actual results and future events could differ materially from those anticipated in this news release. Accordingly, readers should not place undue reliance on the forward-looking information or FOFI contained in this news release. Mednow does not undertake any obligation to publicly update or revise any forward-looking information or FOFI other than as required under applicable securities laws.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005487/en/